Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Involvement of the DNA mismatch repair system in antineoplastic drug resistance

1 Apr 1999

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to DNA Repair Mechanisms
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 10235469
DOI: 10.1007/s004320050258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Involvement of the DNA mismatch repair system in antineoplastic drug resistancePMID 10235469Read ↗

Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directionsSemantic proximity Read ↗

Mismatch repair defects as a cause of resistance to cytotoxic drugs.Semantic proximity Read ↗

Human mismatch repair, drug-induced DNA damage, and secondary cancerSemantic proximity Read ↗

DNA repair and the contribution to chemotherapy resistanceSemantic proximity Read ↗

Biomarkers for chemotherapy and drug resistance in the mismatch repair pathwaySemantic proximity Read ↗

DNA mismatch repair in cancerSemantic proximity Read ↗

The mismatch repair-dependent DNA damage response: Mechanisms and implicationsSemantic proximity Read ↗

Small-molecule drug repurposing to target DNA damage repair and response pathwaysSemantic proximity Read ↗

Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the artSemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategiesSemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implicationsSemantic proximity Read ↗

Exploiting DNA mismatch repair deficiency as a therapeutic strategySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.